These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2925055

  • 1. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 4. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 5. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC, Westaby D, Williams R.
    Gut; 1988 Jun 15; 29(6):752-5. PubMed ID: 3384359
    [Abstract] [Full Text] [Related]

  • 6. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.
    J Hepatol; 1994 Apr 15; 20(4):542-7. PubMed ID: 8051395
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.
    Hepatology; 1994 Dec 15; 20(6):1502-8. PubMed ID: 7982651
    [Abstract] [Full Text] [Related]

  • 9. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M, Sacerdoti D, Merkel C, Gatta A.
    J Ultrasound Med; 1994 Dec 15; 13(12):945-52. PubMed ID: 7877205
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.
    Hepatology; 1990 Feb 15; 11(2):230-8. PubMed ID: 2307401
    [Abstract] [Full Text] [Related]

  • 11. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C, Finucci G, Zuin R, Bazzerla G, Bolognesi M, Sacerdoti D, Gatta A.
    J Hepatol; 1987 Apr 15; 4(2):174-80. PubMed ID: 3584925
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.
    J Gastroenterol; 1994 Aug 15; 29(4):460-8. PubMed ID: 7951857
    [Abstract] [Full Text] [Related]

  • 13. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
    Piscaglia F, Donati G, Gaiani S, Gramantieri L, Leoni S, Mancini M, Bolondi L.
    Dig Liver Dis; 2004 Sep 15; 36(9):594-602. PubMed ID: 15460844
    [Abstract] [Full Text] [Related]

  • 14. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.
    Hepatology; 1989 Sep 15; 10(3):283-7. PubMed ID: 2759546
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J.
    J Hepatol; 1996 Apr 15; 24(4):430-5. PubMed ID: 8738729
    [Abstract] [Full Text] [Related]

  • 17. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Apr 15; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.
    J Hepatol; 1989 May 15; 8(3):316-24. PubMed ID: 2732445
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.